Invention Grant
- Patent Title: Inhibitors of Akt activity
-
Application No.: US12526164Application Date: 2008-02-07
-
Publication No.: US08420690B2Publication Date: 2013-04-16
- Inventor: Mark Andrew Seefeld , Meagan B. Rouse
- Applicant: Mark Andrew Seefeld , Meagan B. Rouse
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent Wayne J. Dustman; Edward R. Gimmi
- International Application: PCT/US2008/053277 WO 20080207
- International Announcement: WO2008/098105 WO 20080814
- Main IPC: A01N43/56
- IPC: A01N43/56 ; A01N43/38 ; A61K31/415 ; A61K31/40 ; C07D231/00 ; C07D403/00 ; C07D403/02 ; C07D231/10 ; C07D231/12
Abstract:
Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
Public/Granted literature
- US20110053972A1 INHIBITORS OF AKT ACTIVITY Public/Granted day:2011-03-03
Information query
IPC分类:
